BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22745589)

  • 1. Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment.
    Jung Y; Shiozawa Y; Wang J; McGregor N; Dai J; Park SI; Berry JE; Havens AM; Joseph J; Kim JK; Patel L; Carmeliet P; Daignault S; Keller ET; McCauley LK; Pienta KJ; Taichman RS
    Neoplasia; 2012 May; 14(5):429-39. PubMed ID: 22745589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.
    Jung Y; Decker AM; Wang J; Lee E; Kana LA; Yumoto K; Cackowski FC; Rhee J; Carmeliet P; Buttitta L; Morgan TM; Taichman RS
    Oncotarget; 2016 May; 7(18):25698-711. PubMed ID: 27028863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G
    Lee E; Decker AM; Cackowski FC; Kana LA; Yumoto K; Jung Y; Wang J; Buttitta L; Morgan TM; Taichman RS
    J Cell Biochem; 2016 Dec; 117(12):2815-2824. PubMed ID: 27153245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GAS6 receptor status is associated with dormancy and bone metastatic tumor formation.
    Taichman RS; Patel LR; Bedenis R; Wang J; Weidner S; Schumann T; Yumoto K; Berry JE; Shiozawa Y; Pienta KJ
    PLoS One; 2013; 8(4):e61873. PubMed ID: 23637920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow.
    Decker AM; Jung Y; Cackowski FC; Yumoto K; Wang J; Taichman RS
    Mol Cancer Res; 2017 Dec; 15(12):1644-1655. PubMed ID: 28814453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.
    Shiozawa Y; Pedersen EA; Patel LR; Ziegler AM; Havens AM; Jung Y; Wang J; Zalucha S; Loberg RD; Pienta KJ; Taichman RS
    Neoplasia; 2010 Feb; 12(2):116-27. PubMed ID: 20126470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caprylic acid (C8:0) promotes bone metastasis of prostate cancer by dysregulated adipo-osteogenic balance in bone marrow.
    Wang C; Wang J; Chen K; Pang H; Li X; Zhu J; Ma Y; Qiu T; Li W; Xie J; Zhang J
    Cancer Sci; 2020 Oct; 111(10):3600-3612. PubMed ID: 32770813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.
    Yumoto K; Eber MR; Wang J; Cackowski FC; Decker AM; Lee E; Nobre AR; Aguirre-Ghiso JA; Jung Y; Taichman RS
    Sci Rep; 2016 Nov; 6():36520. PubMed ID: 27819283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
    Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
    Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblastic protein kinase D1 contributes to the prostate cancer cells dormancy via GAS6-circadian clock signaling.
    Li G; Fan M; Zheng Z; Zhang Y; Zhang Z; Huang Z; Luo W; Zhao W; Lai X; Chen H; Zeng F; Deng F
    Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119296. PubMed ID: 35595103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
    Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
    Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical Changes in the Niche Following Tumor Cell Invasion.
    Decker AM; Cackowski FC; Jung Y; Taichman RS
    J Cell Biochem; 2017 Aug; 118(8):1956-1964. PubMed ID: 27982511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.
    Arnold RS; Sun CQ; Richards JC; Grigoriev G; Coleman IM; Nelson PS; Hsieh CL; Lee JK; Xu Z; Rogatko A; Osunkoya AO; Zayzafoon M; Chung L; Petros JA
    Prostate; 2009 Jan; 69(1):1-11. PubMed ID: 18850577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
    Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
    J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow.
    Jung Y; Cackowski FC; Yumoto K; Decker AM; Wang Y; Hotchkin M; Lee E; Buttitta L; Taichman RS
    Neoplasia; 2021 Jan; 23(1):102-111. PubMed ID: 33296752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone.
    Li X; Liao J; Park SI; Koh AJ; Sadler WD; Pienta KJ; Rosol TJ; McCauley LK
    Bone; 2011 Jun; 48(6):1354-61. PubMed ID: 21419883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models of Prostate Cancer Bone Metastasis.
    Park SH; Eber MR; Shiozawa Y
    Methods Mol Biol; 2019; 1914():295-308. PubMed ID: 30729472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis.
    Elshafae SM; Dirksen WP; Alasonyalilar-Demirer A; Breitbach J; Yuan S; Kantake N; Supsavhad W; Hassan BB; Attia Z; Alstadt LB; Rosol TJ
    Prostate; 2020 Jun; 80(9):698-714. PubMed ID: 32348616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.